CVE-2026-72865
Authenticated path injection allows command execution on Dokploy host.
Is CVE-2026-72865 being exploited?
Not confirmed. CVE-2026-72865 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 0.35% probability of exploitation in the next 30 days.
How severe is CVE-2026-72865?
CVE-2026-72865 is rated Critical with a CVSS score of 9.9. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-72865?
Yes. A fix has been recorded for CVE-2026-72865. The vendor advisory is the authority on the exact fixed version — apply it from there rather than from a summary.
What does CVE-2026-72865 affect?
CVE-2026-72865 affects Dokploy <= 0.29.12, Self-hosted Dokploy PaaS instances, Docker hosts running Dokploy. Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-72865?
Upgrade to Dokploy 0.29.13; restrict compose write/deploy, isolate hosts, and review logs.
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Authenticated user with compose write+deploy can execute arbitrary OS commands in Docker-privileged host, enabling RCE and full host takeover.
Immediate action required
- affected< 0.29.13
As published in the CVE Program record. A version outside these ranges is not a statement that it is unaffected — vendors sometimes understate a range, and distribution-backported builds carry upstream numbers that do not reflect what was patched into them.